SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...
This retrospective analysis is published in Naunyn-Schmiedeberg's Archives of Pharmacology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback